• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从非酒精性脂肪性肝病(NAFLD)到代谢相关性脂肪性肝病(MAFLD):基于人群的横断面研究中患病率和系统性炎症水平的变化。

Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study.

机构信息

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, University Town, No 1, Xue Yuan Road, Fuzhou, 350108, Fujian, China.

Department of Ultrasonography, Fuqing Hospital, Fuqing, China.

出版信息

Lipids Health Dis. 2023 Oct 28;22(1):185. doi: 10.1186/s12944-023-01947-4.

DOI:10.1186/s12944-023-01947-4
PMID:37898739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10613356/
Abstract

BACKGROUND

Variations in the prevalence and systemic inflammatory (SI) status between non-alcoholic fatty liver disease (NAFLD) and newly defined metabolic dysfunction-associated fatty liver disease (MAFLD) have only been reported by few studies. Hence, this study aimed to compile data on the prevalence and the systemic inflammation levels of MAFLD and NAFLD in a general population from Southeast China was summarized to explore the potential effect of the transformation of disease definition.

METHODS

A total of 6718 general population participants aged 35-75 were enrolled. Logistic regression and restricted cubic spline (RCS) models were used to examine the relationship between 15 SI indicators and NAFLD and MAFLD. The predicted values of MAFLD and NAFLD were analyzed using the receiver operating characteristic (ROC) curve.

RESULTS

The prevalence of MAFLD and NAFLD was 34.7% and 32.4%, respectively. Their overlapping rate was 89.7%, while only 8.3% and 1.9% of participants were MAFLD-only and NAFLD-only. Among three FLD groups, the MAFLD-only group had the highest levels of 8 SI indicators, including CRP, WBC, LYMPH, NEUT, MONO, ALB, NLR, and SIRI. The non-FLD group had the lower levels of all 15 SI indicators compared with all FLD subgroups. The odds ratios (ORs) of 10 SI indicators were significant in both multivariable-adjusted logistic regression and RCS analyses of MAFLD or NAFLD, including CRP, WBC, LYMPH, NEUT, MONO, ALB, PLR, LMR, ALI and CA. ROC analysis showed that the AUC values of all SI were lower than 0.7 in both MAFLD and NAFLD.

CONCLUSIONS

MAFLD could cover more FLD than NAFLD, and the MAFLD-only group had a more severe inflammation status, whereas the NAFLD-only exhibited lower levels. Moreover, there was not a high AUC and a high sensitivity of SI indicators, suggesting that SI indicators are not good indicators to diagnose NAFLD/MAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)和新定义的代谢功能相关脂肪性肝病(MAFLD)之间的患病率和系统性炎症(SI)状态的差异仅被少数研究报道。因此,本研究旨在汇总中国东南部一般人群中 MAFLD 和 NAFLD 的患病率和系统炎症水平数据,以探讨疾病定义转变的潜在影响。

方法

共纳入 6718 名年龄在 35-75 岁的一般人群。使用逻辑回归和限制立方样条(RCS)模型来研究 15 个 SI 指标与 NAFLD 和 MAFLD 的关系。使用受试者工作特征(ROC)曲线分析 MAFLD 和 NAFLD 的预测值。

结果

MAFLD 和 NAFLD 的患病率分别为 34.7%和 32.4%,重叠率为 89.7%,而只有 8.3%和 1.9%的参与者为 MAFLD 仅有和 NAFLD 仅有。在三个 FLD 组中,MAFLD 仅有组的 8 个 SI 指标水平最高,包括 CRP、WBC、LYMPH、NEUT、MONO、ALB、NLR 和 SIRI。非 FLD 组的所有 15 个 SI 指标水平均低于所有 FLD 亚组。多变量调整后的逻辑回归和 RCS 分析显示,MAFLD 或 NAFLD 中 10 个 SI 指标的比值比(OR)均有统计学意义,包括 CRP、WBC、LYMPH、NEUT、MONO、ALB、PLR、LMR、ALI 和 CA。ROC 分析显示,MAFLD 和 NAFLD 中所有 SI 的 AUC 值均低于 0.7。

结论

MAFLD 比 NAFLD 能涵盖更多的 FLD,MAFLD 仅有组的炎症状态更严重,而 NAFLD 仅有组的水平较低。此外,SI 指标的 AUC 值不高,灵敏度也不高,提示 SI 指标不是诊断 NAFLD/MAFLD 的良好指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/d5f54b43c3be/12944_2023_1947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/6ecdce145d8d/12944_2023_1947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/8f6cd3ac26fc/12944_2023_1947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/d5f54b43c3be/12944_2023_1947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/6ecdce145d8d/12944_2023_1947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/8f6cd3ac26fc/12944_2023_1947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c3/10613356/d5f54b43c3be/12944_2023_1947_Fig3_HTML.jpg

相似文献

1
Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study.从非酒精性脂肪性肝病(NAFLD)到代谢相关性脂肪性肝病(MAFLD):基于人群的横断面研究中患病率和系统性炎症水平的变化。
Lipids Health Dis. 2023 Oct 28;22(1):185. doi: 10.1186/s12944-023-01947-4.
2
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.代谢相关脂肪性肝病与中国成年人死亡风险的前瞻性队列研究。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e745-e755. doi: 10.1210/clinem/dgab644.
3
Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.代谢相关脂肪性肝病可提高肝硬度检测的检出率:鹿特丹研究。
Hepatology. 2022 Feb;75(2):419-429. doi: 10.1002/hep.32131. Epub 2021 Dec 13.
4
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.代谢功能障碍相关脂肪性肝病与心血管疾病发病风险:一项全国性队列研究。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2138-2147.e10. doi: 10.1016/j.cgh.2020.12.022. Epub 2020 Dec 22.
5
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病与冠状动脉钙化的比较关联:一项横断面和纵向队列研究。
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):482-491. doi: 10.1161/ATVBAHA.122.318661. Epub 2023 Feb 2.
6
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.代谢相关脂肪性肝病与慢性肾脏病发病风险的关系:一项全国性队列研究。
Diabetes Metab. 2022 Jul;48(4):101344. doi: 10.1016/j.diabet.2022.101344. Epub 2022 Mar 25.
7
Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.代谢相关脂肪性肝病无创指标筛查的验证:新疆农村维吾尔族人群的横断面研究。
Eur J Med Res. 2023 Dec 2;28(1):555. doi: 10.1186/s40001-023-01536-2.
8
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort.上海出生队列中青春期前儿童 MAFLD 的患病率和发病率及相关人体测量参数。
Hepatol Int. 2023 Dec;17(6):1416-1428. doi: 10.1007/s12072-023-10574-1. Epub 2023 Sep 20.
9
Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study.代谢功能障碍相关脂肪性肝病增加结直肠癌风险:一项全国性队列研究。
Clin Transl Gastroenterol. 2022 Jan 12;13(1):e00435. doi: 10.14309/ctg.0000000000000435.
10
A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study.中国当代城市健康成年人中 NAFLD 和 MAFLD 诊断标准的比较:一项横断面研究。
BMC Gastroenterol. 2022 Nov 19;22(1):471. doi: 10.1186/s12876-022-02576-4.

引用本文的文献

1
Association of dietary inflammatory index with liver fibrosis and fatty liver index in a population with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.膳食炎症指数与代谢功能障碍相关脂肪性肝病患者肝纤维化及脂肪肝指数的关联:一项横断面研究。
Front Nutr. 2025 Jun 24;12:1594192. doi: 10.3389/fnut.2025.1594192. eCollection 2025.
2
Association of cardiovascular health with MAFLD and mortality in overweight and obese adults and mediation by inflammation and insulin resistance.超重和肥胖成年人中心血管健康与MAFLD及死亡率的关联以及炎症和胰岛素抵抗的中介作用
Sci Rep. 2025 May 29;15(1):18791. doi: 10.1038/s41598-025-03820-z.
3

本文引用的文献

1
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease.白细胞介素-17作为银屑病与代谢相关脂肪性肝病发病机制联系的重要作用。
Life (Basel). 2023 Feb 2;13(2):419. doi: 10.3390/life13020419.
2
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease.与代谢功能障碍相关的脂肪性肝病比非酒精性脂肪性肝病能更好地识别出具有心血管疾病风险的受试者。
Liver Int. 2023 Mar;43(3):608-625. doi: 10.1111/liv.15508. Epub 2023 Jan 11.
3
Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease.
Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in metabolic dysfunction associated steatotic liver disease.
代谢功能障碍相关脂肪性肝病中晚期肺癌炎症指数与全因死亡率和心血管死亡率的关联
Sci Rep. 2025 Apr 29;15(1):15121. doi: 10.1038/s41598-025-99311-2.
4
The Mediation Role of Insulin Resistance and Chronic Systemic Inflammation in the Association Between Obesity and NAFLD: Two Cross-Sectional and a Mendelian Randomization Study.胰岛素抵抗和慢性全身炎症在肥胖与非酒精性脂肪性肝病关联中的中介作用:两项横断面研究和一项孟德尔随机化研究
Clin Epidemiol. 2025 Mar 24;17:287-302. doi: 10.2147/CLEP.S508514. eCollection 2025.
5
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017-2020.全身炎症生物标志物与代谢功能障碍相关脂肪性肝病之间的关联:一项2017 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究
BMC Gastroenterol. 2025 Jan 29;25(1):42. doi: 10.1186/s12876-025-03625-4.
6
The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis.免疫炎症生物标志物中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)与非酒精性脂肪性肝病之间的关联:一项系统评价和荟萃分析。
Clin Exp Med. 2025 Jan 15;25(1):39. doi: 10.1007/s10238-024-01539-1.
7
A screening study of high-risk groups for liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.代谢相关脂肪性肝病患者肝纤维化高危人群的筛查研究。
Sci Rep. 2024 Oct 10;14(1):23714. doi: 10.1038/s41598-024-74792-9.
8
The mediating role of insulin resistance in the association between inflammatory score and MAFLD: NHANES 2017-2018.胰岛素抵抗在炎症评分与 MAFLD 之间的关联中的中介作用:NHANES 2017-2018。
Immun Inflamm Dis. 2024 Oct;12(10):e70035. doi: 10.1002/iid3.70035.
9
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.肠道微生物群和免疫细胞在代谢相关脂肪性肝病中的作用:临床影响。
Hepatol Int. 2024 Oct;18(Suppl 2):861-872. doi: 10.1007/s12072-024-10674-6. Epub 2024 Jul 12.
10
Associations of life's essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study.美国成年人中生命必需的8项指标与MAFLD及肝纤维化的关联:一项全国性横断面研究。
Front Nutr. 2024 Jun 12;11:1403720. doi: 10.3389/fnut.2024.1403720. eCollection 2024.
基于实验室指标比值的新型炎症生物标志物对非酒精性脂肪性肝病的诊断性能。
Front Endocrinol (Lausanne). 2022 Nov 28;13:981196. doi: 10.3389/fendo.2022.981196. eCollection 2022.
4
MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men.在男性中,MAFLD通过全身性炎症与慢性阻塞性肺疾病(COPD)相关,且独立于衰老和吸烟因素。
Diabetol Metab Syndr. 2022 Aug 16;14(1):115. doi: 10.1186/s13098-022-00887-w.
5
Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.性别特异性代谢风险因素及其与非酒精性脂肪性肝病发病率的关系轨迹。
J Endocrinol Invest. 2022 Dec;45(12):2233-2245. doi: 10.1007/s40618-022-01848-w. Epub 2022 Jul 27.
6
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.免疫机制将代谢损伤与脂肪肝疾病中的炎症和纤维化联系起来——细胞通讯回路的新见解。
J Hepatol. 2022 Oct;77(4):1136-1160. doi: 10.1016/j.jhep.2022.06.012. Epub 2022 Jun 22.
7
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease.腹部肥胖、慢性炎症与非酒精性脂肪性肝病风险。
Ann Hepatol. 2023 Jul-Aug;28(4):100726. doi: 10.1016/j.aohep.2022.100726. Epub 2022 May 27.
8
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease.炎症细胞因子与非酒精性脂肪性肝病的关系。
Front Immunol. 2022 May 6;13:880298. doi: 10.3389/fimmu.2022.880298. eCollection 2022.
9
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study.比较中国人群中MAFLD与NAFLD的诊断标准:一项基于人群的前瞻性队列研究。
J Clin Transl Hepatol. 2022 Feb 28;10(1):6-16. doi: 10.14218/JCTH.2021.00089. Epub 2021 Jul 1.
10
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.中国 40 岁及以上成年人 MAFLD 的患病率及特征:一项基于社区的研究。
Hepatobiliary Pancreat Dis Int. 2022 Apr;21(2):154-161. doi: 10.1016/j.hbpd.2022.01.006. Epub 2022 Jan 31.